Josh joined the Health System in 2011 as a writer and editor. He previously worked at The Daily Progress newspaper in Charlottesville, Va., first as a reporter and then as an editor. He is a graduate of UVA. Josh primarily covers research and the School of Medicine.
An international research consortium studying 520,000 individuals from around the world has identified 22 new genetic risk factors for stroke, thus tripling the number of gene regions known to affect stroke risk. The results demonstrate shared genetic influences with multiple related vascular conditions, especially blood pressure, but also coronary artery disease, venous thromboembolism and… read more >
A new discovery about the immune system may allow doctors to treat harmful inflammation that damages the brain in neurodegenerative diseases such as Alzheimer’s. It might also let doctors save patients from the potentially deadly inflammation of sepsis, a full-body infection that kills a quarter-million Americans every year.
The finding “opens up a whole new… read more >
The Alzheimer’s Association is awarding the School of Medicine’s John Lukens, PhD, a 2018 Research Grant Award. This funding will support research critical to developing more-effective strategies for detecting/treating/preventing Alzheimer’s.
The grant award provides Dr. Lukens $149,820 over three years to study lymphatic dysfunction and inflammasomes as drivers of Alzheimer’s disease pathology.
The Alzheimer’s Association is… read more >
The UVA Licensing & Ventures Group has named W. Jeffrey Elias, MD, the 2018 Edlich-Henderson Innovator of the Year, an award given to university faculty members whose research is making a major impact on society. Elias is recognized for pioneering the use of focused ultrasound to treat essential tremor, and for leading… read more >
A new discovery from the School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted anemia that leaves millions of people weak, tired and unable to concentrate – and may point the way to better treatments.
Adam… read more >
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.
The experimental procedure uses… read more >
Talk about shedding light on the unknown: A School of Medicine researcher has developed a way to set biological matter aglow that is 100 times brighter than what scientists commonly use. This offers major advantages to medical researchers who use bioluminescence to track cancer tumors, chart biological processes, understand the functions of genes… read more >
The evidence is clear: Cervical cancer is best treated with brachytherapy, a form of radiation therapy. Yet the use of this potentially lifesaving treatment has been declining, and a new study from the School of Medicine may explain why.
UVA researchers have determined that offering brachytherapy for locally advanced cervical cancer actually ends up… read more >
Infections caused by the C. difficile bacteria are a serious health threat, especially for older people. But researchers at the University of Virginia School of Medicine have found that simply altering the bacteria in our guts may dramatically improve outcomes for patients with the life-threatening illness.
The work adds to the mounting evidence that the… read more >
In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight. The finding may allow doctors to halt the inflammation… read more >